Carregant...
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/202881
C-Reactive Protein, a Promising Approach for Acetaminophen Hepatotoxicity
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Drug-induced liver injury is a major cause of acute liver failure (ALF) and one of the most challenging liver disorders with respect to its prediction, diagnosis, and management. Acetaminophen (APAP) is one of the most widely used pain relievers worldwide. Although relatively safe, APAP is a dose-dependent hepatotoxin and APAP overdose is a major cause of ALF, far exceeding other causes of ALF in industrialized countries. APAP hepatotoxicity in humans can be modelled in rodents after administration of an acute or cumulative overdose. However, despite intensive efforts, the mechanisms involved in APAP hepatotoxicity are not fully understood, which has hampered the availability of effective therapy for APAP hepatotoxicity.1,2 N-acetylcysteine (NAC) is the standard treatment for APAP hepatotoxicity and other causes of ALF.3 However, the effectiveness of NAC in APAP hepatotoxicity is limited to early administration, indicating the need to identify new strategies for adequate management of ALF caused by APAP hepatotoxicity.
Matèries
Matèries (anglès)
Citació
Citació
GARCÍA RUIZ, Carmen, FERNÁNDEZ CHECA TORRES, José carlos. C-Reactive Protein, a Promising Approach for Acetaminophen Hepatotoxicity. _Cellular and Molecular Gastroenterology and Hepatology_. 2022. Vol. 13, núm. 1, pàgs. 341-342. [consulta: 25 de gener de 2026]. ISSN: 2352-345X. [Disponible a: https://hdl.handle.net/2445/202881]